-
公开(公告)号:US20220081425A1
公开(公告)日:2022-03-17
申请号:US17478187
申请日:2021-09-17
IPC: C07D405/06 , A61P27/06 , A61K9/00 , A61K31/4178 , A61K45/06
Abstract: The present disclosure provides pilocarpine ionic liquid analogs useful in the treatment of ophthalmological disorders such as glaucoma.
-
公开(公告)号:US20210205472A1
公开(公告)日:2021-07-08
申请号:US15998948
申请日:2017-02-17
Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
Inventor: Yan ZHANG , Hu YANG , Dana SELLEY , William DEWEY , Hamid AKBARALI
IPC: A61K47/69 , A61K31/485
Abstract: Provided herein are nanoparticle conjugated synthetic opioid prodrugs that target the peripheral mu opioid receptor (MOR). The prodrugs exhibit long-lived bioavailability, do not compromise the analgesic effects of opioids administered for pain relief (and in some cases can be used for pain relief), and do not induce opioid withdrawal symptoms, when their use is discontinued. Certain of the prodrugs are especially useful for the prevention and/or treatment of unwanted opioid-induced side effects such as opioid-induced constipation (OIC).
-
公开(公告)号:US20220010076A1
公开(公告)日:2022-01-13
申请号:US17297853
申请日:2019-11-27
Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
IPC: C08J3/05 , A61K47/36 , C08L5/08 , A61K8/73 , A23L29/275
Abstract: A method is provided for producing a composition comprising chitosan and water, comprising dissolving chitosan powder in an ionic liquid, to prepare a first composition comprising chitosan and ionic liquid; and contacting the first composition with water under conditions sufficient to solvent-exchange all or substantially all of the ionic liquid with water; to form a composition comprising chitosan and water. Compositions produced thereby and methods of using the compositions are provided.
-
公开(公告)号:US20210154202A1
公开(公告)日:2021-05-27
申请号:US17048586
申请日:2019-04-16
Applicant: Virginia Commonwealth University
Inventor: Michael LANCINA , Juan WANG , Hu YANG
Abstract: Compounds, comprising a selective β-blocker coupled to a PAMAM dendrimer via a flexible spacer, and compositions containing the compounds, are provided. Methods of making and using the compounds and compositions for the treatment of glaucoma and other maladies are also provided.
-
-
-